bluebird bio Statistics
Total Valuation
bluebird bio has a market cap or net worth of $96.78 million. The enterprise value is $350.99 million.
Important Dates
The next estimated earnings date is Tuesday, November 5, 2024, before market open.
Earnings Date | Nov 5, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
bluebird bio has 193.91 million shares outstanding. The number of shares has increased by 62.35% in one year.
Shares Outstanding | 193.91M |
Shares Change (YoY) | +62.35% |
Shares Change (QoQ) | +0.29% |
Owned by Insiders (%) | 0.46% |
Owned by Institutions (%) | 40.82% |
Float | 193.02M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.43 |
Forward PS | 0.52 |
PB Ratio | 1.88 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 6.39 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.68, with a Debt / Equity ratio of 7.47.
Current Ratio | 0.68 |
Quick Ratio | 0.53 |
Debt / Equity | 7.47 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -18.80 |
Financial Efficiency
Return on equity (ROE) is -186.70% and return on invested capital (ROIC) is -41.93%.
Return on Equity (ROE) | -186.70% |
Return on Assets (ROA) | -36.24% |
Return on Capital (ROIC) | -41.93% |
Revenue Per Employee | $146,400 |
Profits Per Employee | -$851,336 |
Employee Count | 375 |
Asset Turnover | 0.09 |
Inventory Turnover | 3.24 |
Taxes
Income Tax | -25,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.69% in the last 52 weeks. The beta is 0.79, so bluebird bio's price volatility has been lower than the market average.
Beta (5Y) | 0.79 |
52-Week Price Change | -82.69% |
50-Day Moving Average | 0.55 |
200-Day Moving Average | 0.97 |
Relative Strength Index (RSI) | 44.53 |
Average Volume (20 Days) | 5,312,222 |
Short Selling Information
The latest short interest is 48.99 million, so 25.26% of the outstanding shares have been sold short.
Short Interest | 48.99M |
Short Previous Month | 48.40M |
Short % of Shares Out | 25.26% |
Short % of Float | 25.38% |
Short Ratio (days to cover) | 6.46 |
Income Statement
In the last 12 months, bluebird bio had revenue of $54.90 million and -$319.25 million in losses. Loss per share was -$2.08.
Revenue | 54.90M |
Gross Profit | -21.23M |
Operating Income | -350.38M |
Pretax Income | -91.14M |
Net Income | -319.25M |
EBITDA | -302.11M |
EBIT | -350.38M |
Loss Per Share | -$2.08 |
Full Income Statement Balance Sheet
The company has $144.07 million in cash and $395.64 million in debt, giving a net cash position of -$251.57 million or -$1.30 per share.
Cash & Cash Equivalents | 144.07M |
Total Debt | 395.64M |
Net Cash | -251.57M |
Net Cash Per Share | -$1.30 |
Equity (Book Value) | 52.98M |
Book Value Per Share | 0.27 |
Working Capital | -94.41M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$245.12 million and capital expenditures -$5.09 million, giving a free cash flow of -$250.20 million.
Operating Cash Flow | -245.12M |
Capital Expenditures | -5.09M |
Free Cash Flow | -250.20M |
FCF Per Share | -$1.29 |
Full Cash Flow Statement Margins
Gross Margin | -38.67% |
Operating Margin | -638.21% |
Pretax Margin | -581.56% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -394.16% |
Dividends & Yields
bluebird bio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -62.35% |
Shareholder Yield | -62.35% |
Earnings Yield | -321.12% |
FCF Yield | -251.66% |
Analyst Forecast
The average price target for bluebird bio is $4.63, which is 827.67% higher than the current price. The consensus rating is "Hold".
Price Target | $4.63 |
Price Target Difference | 827.67% |
Analyst Consensus | Hold |
Analyst Count | 11 |
Revenue Growth Forecast (5Y) | 74.92% |
EPS Growth Forecast (5Y) | -54.55% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
bluebird bio has an Altman Z-Score of -13.2 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -13.2 |
Piotroski F-Score | 2 |